跳至主要内容
临床试验/PACTR202105562059108
PACTR202105562059108尚未招募未知

The use of culture medium supplemented with Granulocyte-Macrophage Colony-Stimulating Factor for Recurrent Pregnancy Loss Patients, A pilot study on 200 cases.

Adam Internntional Hospital0 个研究点目标入组 200 人开始时间: 2021年2月9日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Women aged 19 to 44 years and had a history recurrent miscarriage: loss of two or more consecutive pregnancies before 20 weeks.
  • Those women should have a regular menstrual cycle of 21 to 35 days, treated per standard protocols.

排除标准

  • Women aged over 44 or had an anatomic disorder of the uterus, chromosomal defects in the couple, medical conditions or genetic disorders prohibiting IVF/ICSI or interfering with the interpretation of results.
  • ICSI cycles requiring pre-implantation genetic diagnosis.

研究者

发起方
Adam Internntional Hospital

相似试验